Chlorogenic Acid (Hydroxycinnamic Acid · Blood Glucose · Weight Management)

Compound	Chlorogenic Acid (CGA)
Chemical class	Polyphenol — Hydroxycinnamic Acid Ester (Caffeoylquinic Acid)
CAS	327-97-9
Primary source	Coffea arabica (green coffee beans), Ilex paraguariensis (mate), Solanum tuberosum (potato)
Key applications	Blood glucose, weight management, cardiovascular, antioxidant
Claim strength	Moderate
Typical form	Green coffee extract standardised to chlorogenic acids (45–50% CGA)
Buy from Herbuno	Green Coffee Extract Powder - Coffea arabica → Green Coffee Oil Soluble Extract - Coffea arabica →

Name origin: “Chloro” from Greek chloros (green) — reflecting the green colour chlorogenic acid produces when oxidised in alkaline conditions, not its chlorine content. It is an ester of caffeic acid and quinic acid — hence the systematic name 3-caffeoylquinic acid (3-CQA). Traditional use: Green coffee beans (unroasted Coffea arabica) have not historically been consumed as a beverage — the roasting process destroys most chlorogenic acids. However, green coffee preparations and mate (Ilex paraguariensis), which retains chlorogenic acid, have traditional use across South American cultures for energy, weight management, and metabolic health. Research trajectory: Chlorogenic acid has a substantial clinical evidence base for blood glucose modulation, weight management support, and blood pressure reduction, primarily from green coffee extract studies. It is one of the most commercially established botanical actives for metabolic supplement positioning. Commercial source: Green coffee extract standardised to chlorogenic acids is commercially available at 45–50% CGA content. See sourcing options below.

---

Evidence for Chlorogenic Acid Applications

Blood glucose and insulin sensitivity: Chlorogenic acid inhibits glucose-6-phosphatase (reducing hepatic glucose output) and alpha-glucosidase (slowing intestinal glucose absorption), providing dual-mechanism blood glucose modulation. Multiple human RCTs with green coffee extract (800–1200 mg/day, 45% CGA) show reductions in fasting blood glucose and post-prandial glucose spikes. Claim strength: Moderate.

Weight management: A systematic review of green coffee extract RCTs found modest but consistent reductions in body weight (mean ~2.5 kg over 4–12 weeks) and waist circumference. Mechanisms include reduced glucose absorption, inhibition of fat accumulation, and potential sympathomimetic effects from residual caffeine. Claim strength: Moderate.

Blood pressure reduction: Human RCTs with chlorogenic acid-enriched green coffee extract demonstrate reductions of 3–8 mmHg systolic blood pressure over 4–12 weeks, attributed to ACE inhibition and eNOS activation. Relevant for cardiovascular risk management formulations. Claim strength: Moderate.

---

Dosage & Formulator Specification

Clinical dose range: 400–800 mg/day chlorogenic acids (as green coffee extract, 45–50% CGA standardisation). For a 45% CGA extract, 800–1200 mg/day extract delivers the effective dose. Divide into two doses with meals for optimal glucose management timing.

Specify green coffee extract by total chlorogenic acid content (HPLC, 45–50% minimum) and confirm caffeine content — green coffee extract retains significant caffeine unless decaffeinated. For caffeine-sensitive applications or clean stimulant-free formulations, specify decaffeinated green coffee extract with verified CGA retention (decaffeination should not significantly reduce CGA content if properly executed).

Chlorogenic acids are relatively water-soluble and bioavailable. They are absorbed in the small intestine and also in the colon (following microbial hydrolysis to caffeic acid and quinic acid). Thermolabile — avoid extended high-temperature processing which degrades CGA, consistent with why roasting destroys most coffee bean CGA. Stable in dry solid formats at room temperature.

---

Frequently Asked Questions — Chlorogenic Acid

Why does roasting coffee destroy chlorogenic acid?
Chlorogenic acids undergo thermal degradation during roasting at 180–230°C, degrading to quinic acid, caffeic acid, and various lactone forms (chlorogenic acid lactones) with different bioactivity profiles. Light roasts retain more CGA than dark roasts, but even light-roasted coffee has significantly less CGA than green (unroasted) beans. This is why green coffee extract is the commercial vehicle for chlorogenic acid supplementation, not regular coffee.

Is green coffee extract the same as regular coffee extract?
No. Green coffee extract is from unroasted beans and is standardised to chlorogenic acid content (45–50% CGA). Regular coffee extract or instant coffee is produced from roasted beans with drastically reduced CGA content. The two products have entirely different bioactive profiles. Green coffee extract typically contains 5–10% caffeine alongside CGA; regular coffee extract composition varies widely.

Can chlorogenic acid be combined with berberine for blood glucose management?
Yes, and this is a rational mechanistic combination. Chlorogenic acid (alpha-glucosidase inhibition + glucose-6-phosphatase inhibition) and berberine (AMPK activation + intestinal glucose absorption inhibition) address complementary mechanisms of glucose control. Both have moderate human RCT support. No adverse interactions are documented. Combined use at moderate doses of each may provide additive benefit.

Is the chlorogenic acid in coffee responsible for any of coffee’s health associations?
Epidemiological studies associate regular coffee consumption with reduced risk of type 2 diabetes, cardiovascular disease, and certain cancers. CGA is considered a major contributing factor alongside caffeine for the metabolic and cardiovascular associations. For hepatoprotective associations, CGA’s anti-fibrotic and antioxidant liver effects are also considered contributory. The coffee health literature collectively supports CGA as a significant bioactive, though attribution is complicated by coffee’s complex polyphenol composition.

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery